nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
|
Moh Moh, Myint Aung |
|
2019 |
16 |
2 |
p. 186-195 |
artikel |
2 |
Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6
|
Adam, Safwaan |
|
2019 |
16 |
2 |
p. 144-152 |
artikel |
3 |
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial
|
Kumar, Anirudh |
|
2019 |
16 |
2 |
p. 171-177 |
artikel |
4 |
Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy
|
Campos, Raquel Munhoz da Silveira |
|
2019 |
16 |
2 |
p. 196-206 |
artikel |
5 |
Effects of obesity on insulin: insulin-like growth factor 1 hybrid receptor expression and Akt phosphorylation in conduit and resistance arteries
|
Mughal, Romana S |
|
2019 |
16 |
2 |
p. 160-170 |
artikel |
6 |
Gerald Reaven: A man for our times
|
Handelsman, Yehuda |
|
2019 |
16 |
2 |
p. 113-115 |
artikel |
7 |
Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial
|
Zhou, Jin J |
|
2019 |
16 |
2 |
p. 178-185 |
artikel |
8 |
Impact of race/ethnicity on insulin resistance and hypertriglyceridaemia
|
Raygor, Viraj |
|
2019 |
16 |
2 |
p. 153-159 |
artikel |
9 |
Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift
|
Nolan, Christopher J |
|
2019 |
16 |
2 |
p. 118-127 |
artikel |
10 |
Insulin resistance: Impact on therapeutic developments in diabetes
|
Bailey, Clifford J |
|
2019 |
16 |
2 |
p. 128-132 |
artikel |
11 |
Personal Memories
|
|
|
2019 |
16 |
2 |
p. 207-209 |
artikel |
12 |
Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
|
DeFronzo, Ralph A |
|
2019 |
16 |
2 |
p. 133-143 |
artikel |
13 |
The Reaven syndrome: An historical perspective
|
Soran, Handrean |
|
2019 |
16 |
2 |
p. 116-117 |
artikel |